Search results for "blee"

showing 10 items of 263 documents

Caracterización y tipificación molecular de cepas de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido (BL…

2021

Introducción: Las betalactamasas de espectro extendido (BLEE) son enzimas producidas principalmente por la familia Enterobacteriaceae y se caracterizan porque inactivan a la práctica totalidad de los antibióticos betalactámicos. El aislamiento clínico de cepas productoras de BLEE es cada vez más frecuente en todo el mundo. Diferentes especies de Enterobacterales pueden ser productoras de BLEE, pero Klebsiella pneumoniae y Escherichia coli son las especies que las producen mayoritariamente. La realización de estudios de caracterización epidemiológica de las cepas productoras de BLEE es fundamental para detectar cualquier cambio en la resistencia y por tanto, para el control de su diseminació…

clonesescherichia coli bleebleeklebsiella pneumoniae bleeUNESCO::CIENCIAS MÉDICAS:CIENCIAS MÉDICAS [UNESCO]resistencia antibiótica
researchProduct

Influence of Biologically Oriented Preparation Technique on Peri-Implant Tissues; Prospective Randomized Clinical Trial with Three-Year Follow-Up. Pa…

2019

Purpose: The objective of this prospective randomized clinical trial (RCT) was to analyze and compare the clinical behavior of three types of prosthesis supported by single implants in the posterior region after three years of functional loading. Materials and methods: Seventy-five implants were divided into three groups according to the type of prosthetic restoration: screw-retained crown (group GS); cemented crown without finishing line (biologically oriented preparation technique) (group GBOPT); and conventional cemented crown with finishing line (group GCC). After three years in function, clinical parameters (presence of keratinized mucosa, probing depths, bleeding on probing, and radio…

complicationsmedicine.medical_treatmentRadiographyBleeding on probingPeriDentistryProsthesisCrown (dentistry)Articlelaw.invention03 medical and health sciencesimplant-supported prosthesis0302 clinical medicineRandomized controlled triallaw0502 economics and businessmedicinebusiness.industry05 social sciencesSoft tissue030206 dentistryGeneral MedicineBOPTscrew-retainedbone loss and clinical parameterscemented050211 marketingImplantmedicine.symptombusinesssoft tissuesJournal of Clinical Medicine
researchProduct

Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey

2022

Abstract We investigated menstrual irregularities after the first and second doses of the COVID-19 vaccine. Women answered a customised online questionnaire (ClinicalTrial.gov ID: NCT05083065) aimed to assess the vaccine type, the phase of the menstrual cycle during which the vaccine was administered, the occurrence of menstrual irregularities after the first and second doses, and how long this effect lasted. We excluded women with gynaecological and non-gynaecological diseases, undergoing hormonal and non-hormonal treatments, in perimenopause or menopause, as well as those who had irregular menstrual cycles in the last 12 months before vaccine administration. According to our data analysis…

covid19mestrual irregularitymenstrual irregularitiesadverse effectvaccineabnormal uterine bleedingCOVID-19General MedicineMenstrual irregularitieabnormal uterine bleeding; adverse effect; COVID-19; menstrual irregularities; vaccine
researchProduct

Accuracy of risk tools to predict critical bleeding in major trauma: A systematic review with meta-analysis.

2021

BACKGROUND Early detection of critical bleeding by accurate tools can help ensure rapid delivery of blood products to improve outcomes in major trauma patients. We conducted a systematic review to evaluate the accuracy of risk tools to predict critical bleeding in patients with major trauma. METHODS PubMed, Embase, and CENTRAL were searched up to February 2021 for studies investigating risk tools to predict critical bleeding for major trauma people in prehospital and emergency department. We followed the Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy study guidelines. Two independent authors included studies, extracted data, appraised the quali…

critical bleedingAdultaccuracyrisk toolHemorrhagemeta-analysis.bleedingCritical Care and Intensive Care MedicineSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatrichemajor traumaSystematic reviewHumansSurgeryTriageChildThe journal of trauma and acute care surgery
researchProduct

Laika ietekme ārkārtas gastroendoskopijas veikšanā uz ārstēšanas iznākumu nevarikozas augšējas GI asiņošanas gadījumā

2018

Darba nosaukums: Laika ietekme ārkārtas gastroendoskopijas veikšanā uz ārstēšanas iznākumu nevarikozas augšējās GI asiņošanas gadījumā. Ievads: Akūta nevarikoza augšējā gastrointestinālā trakta asiņošana ir nopietna medicīniska patoloģija, kas var veicināt tālāku veselības pasliktināšanos un pat nāvi. Šī iemesla dēļ ir svarīgi analizēt agrīnas un vēlīnas ārkārtas endoskopijas ietekmi uz ārstēšanas iznākumu nevarikozas augšējās GI asiņošanas gadījumos. Darba mērķis: Mērķis ir izpētīt, vai agrīna endoskopisko izmeklējumu veikšana pacientam samazina negatīvu iznākumu riskus. Materiāli un metodes: Darbs ir veikts kā retrospektīvs kohortas pētījums. Dati tika ievākti no 2010. līdz 2017. gadam. P…

effectnon-variceal gastrointestinal bleedingsendoscopytimeMedicīna
researchProduct

Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal …

2011

Aliment Pharmacol Ther 2011; 33: 1010–1018 Summary Background  The prognostic value of an elevated international normalised ratio (INR) as part of initial risk stratification in nonvariceal upper gastrointestinal bleeding (NVUGIB) remains poorly characterised. Aim  To assess the usefulness of the initial INR in patients with NVUGIB. Method  After a systematic review, we included the presenting INR and other validated prognosticators in multivariable models predicting rebleeding and mortality. Data are reported as odd ratios and 95% confidence intervals. Results  Only two of 769 candidate studies were useful, but reported disparate, highly selected NVUGIB patients with varying threshold init…

endocrine systemGastrointestinal bleedingmedicine.medical_specialtyHepatologybusiness.industryfungiGastroenterologyMean agemedicine.diseaseConfidence intervalSurgeryhealth services administrationInternal medicineCohortmedicineInternational normalised ratioheterocyclic compoundsPharmacology (medical)In patientcardiovascular diseasesUpper gastrointestinal bleedingYoung adultbusinessAlimentary Pharmacology & Therapeutics
researchProduct

valutazione isteroscopica della cicatrice isterotomica post-cesareo:classificazione,patologie ad essa correlate e trattamento

2010

hysterotomy scar cesarean abnormal uterine bleeding secondary infertilitySettore MED/40 - Ginecologia E Ostetricia
researchProduct

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

2019

Key Clinical Message In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15‐20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

lcsh:MedicineCase ReportCase Reports030204 cardiovascular system & hematologyIntravenous boluslaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawActivated factor VIIpercutaneous tracheostomyMedicinepostoperatory bleedinglcsh:R5-920activated factor VIIFactor VIIbusiness.industrylcsh:RLow doserFVIIaGeneral MedicineThrombocytopeniaPercutaneous dilational tracheostomychemistry030220 oncology & carcinogenesisAnesthesiaPercutaneous tracheostomyRecombinant DNAlcsh:Medicine (General)businessClinical Case Reports
researchProduct

A pouch in the cervix: a strange diagnosis

2016

Anechoic cervical lesions are uncommon findings which may entail diagnostic and, therefore, management difficulties. Chronic cervicitis, bulky nabothian cysts, adenomyomas, niches (cesarean scar defects), congenital malformations, and pseudo-neoplastic glandular cervical lesions often raise diagnostic dilemmas; they may also mimic malignant lesions [1–4]. Other anechoic images worth considering are those produced by cystic changes after cervical trauma, lacerations, or extremely rare false passages resulting from cervical dilatation [5]. Methods

medicine.medical_specialty030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryChronic CervicitisAbnormal uterine bleedingObstetrics and GynecologyInterventional radiologyHysteroscopyCystic Change030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureCervical cystObstetrics and gynaecologyHysteroscopymedicineSurgeryRadiologyPouchCervical dilatationbusinessCervixGynecological Surgery
researchProduct

Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation

2017

SummaryExisting clinical scores do not perform well in predicting bleeding in elderly patients with acute venous thromboembolism (VTE). We sought to derive an easy-to-use clinical score to help physicians identify elderly patients with VTE who are at high-risk of bleeding during extended anticoagulation (>3 months). Our derivation sample included 743 patients aged ≥65 years with VTE who were enrolled in a prospective multicenter cohort study. All patients received extended anticoagulation with vitamin K antagonists. We derived our score using competing risk regression, with the time to a first major bleeding up to 36 months of extended anticoagulation as the outcome, and 17 candidate var…

medicine.medical_specialtyAnemia2720 Hematology610 Medicine & health030204 cardiovascular system & hematology03 medical and health sciencesAnticoagulation0302 clinical medicineElderlyInternal medicineAnticoagulation; Bleeding risk; Elderly; HematologyBleeding riskmedicineDerivation030212 general & internal medicineInternal validation610 Medicine & healthddc:616Framingham Risk Scorebusiness.industry10031 Clinic for AngiologyCancerHematologymedicine.diseaseSurgery10209 Clinic for CardiologybusinessVenous thromboembolismMajor bleeding360 Social problems & social servicesCohort study
researchProduct